Skip to main content
Journal cover image

Single Nucleotide Polymorphisms in CBLB, a Regulator of T-Cell Response, Predict Radiation Pneumonitis and Outcomes After Definitive Radiotherapy for Non-Small-Cell Lung Cancer.

Publication ,  Journal Article
Li, P; Wang, X; Liu, Z; Liu, H; Xu, T; Wang, H; Gomez, DR; Nguyen, Q-N; Wang, L-E; Teng, Y; Song, Y; Komaki, R; Welsh, JW; Wei, Q; Liao, Z
Published in: Clinical lung cancer
July 2016

The immune system has important roles in tumor development and outcomes after cancer treatment. We evaluated whether single-nucleotide polymorphisms (SNPs) in the gene encoding casitas B-lineage lymphoma b protein (Cbl-b), an E3 ubiquitin ligase that maintains immune tolerance by negatively regulating T-cell activation and function, were associated with outcomes after treatment of non-small-cell lung cancer (NSCLC).Samples from 393 patients with NSCLC treated with definitive radiotherapy at a single institution between March 1998 and February 2009 were used to genotype 3 potentially functional SNPs in CBLB (rs1042852 C>T, rs2305035 G>A, and rs7649466 C>G). We evaluated associations between these SNPs and local recurrence-free survival, distant metastasis-free survival, overall survival, and risk of radiation pneumonitis (RP).Having the rs2305035 A variant genotypes (AA or AG) was associated with better local recurrence-free survival (median 15.8 vs. 15.3 months; adjusted hazard ratio [HR], 0.76; 95% confidence interval [CI], 0.60-0.98; P = .033), distant metastasis-free survival (median 15.4 vs. 14.0 months; adjusted HR, 0.74; 95% CI, 0.57-0.96; P = .024) and overall survival (median 23.5 vs. 22.8 months; adjusted HR, 0.72; 95% CI, 0.56-0.93; P = .013) after adjustment in a Cox proportional hazard model. Patients with these genotypes were also at greater risk of developing grade 3 or higher RP than were patients with GG genotypes in an adjusted Cox proportional hazard model.This is the first report that rs2305035 genotypes in CBLB were associated with clinical and RP risk among patients with NSCLC treated with definitive radiotherapy. These findings could assist in generating hypothesis for further mechanistic studies.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Clinical lung cancer

DOI

EISSN

1938-0690

ISSN

1525-7304

Publication Date

July 2016

Volume

17

Issue

4

Start / End Page

253 / 262.e5

Related Subject Headings

  • Treatment Outcome
  • Survival Analysis
  • Radiation Pneumonitis
  • Proto-Oncogene Proteins c-cbl
  • Prognosis
  • Predictive Value of Tests
  • Polymorphism, Single Nucleotide
  • Oncology & Carcinogenesis
  • Middle Aged
  • Male
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Li, P., Wang, X., Liu, Z., Liu, H., Xu, T., Wang, H., … Liao, Z. (2016). Single Nucleotide Polymorphisms in CBLB, a Regulator of T-Cell Response, Predict Radiation Pneumonitis and Outcomes After Definitive Radiotherapy for Non-Small-Cell Lung Cancer. Clinical Lung Cancer, 17(4), 253-262.e5. https://doi.org/10.1016/j.cllc.2015.11.008
Li, Peng, Xiaohong Wang, Zhensheng Liu, Hongliang Liu, Ting Xu, HuiJuan Wang, Daniel R. Gomez, et al. “Single Nucleotide Polymorphisms in CBLB, a Regulator of T-Cell Response, Predict Radiation Pneumonitis and Outcomes After Definitive Radiotherapy for Non-Small-Cell Lung Cancer.Clinical Lung Cancer 17, no. 4 (July 2016): 253-262.e5. https://doi.org/10.1016/j.cllc.2015.11.008.
Li, Peng, et al. “Single Nucleotide Polymorphisms in CBLB, a Regulator of T-Cell Response, Predict Radiation Pneumonitis and Outcomes After Definitive Radiotherapy for Non-Small-Cell Lung Cancer.Clinical Lung Cancer, vol. 17, no. 4, July 2016, pp. 253-262.e5. Epmc, doi:10.1016/j.cllc.2015.11.008.
Li P, Wang X, Liu Z, Liu H, Xu T, Wang H, Gomez DR, Nguyen Q-N, Wang L-E, Teng Y, Song Y, Komaki R, Welsh JW, Wei Q, Liao Z. Single Nucleotide Polymorphisms in CBLB, a Regulator of T-Cell Response, Predict Radiation Pneumonitis and Outcomes After Definitive Radiotherapy for Non-Small-Cell Lung Cancer. Clinical lung cancer. 2016 Jul;17(4):253-262.e5.
Journal cover image

Published In

Clinical lung cancer

DOI

EISSN

1938-0690

ISSN

1525-7304

Publication Date

July 2016

Volume

17

Issue

4

Start / End Page

253 / 262.e5

Related Subject Headings

  • Treatment Outcome
  • Survival Analysis
  • Radiation Pneumonitis
  • Proto-Oncogene Proteins c-cbl
  • Prognosis
  • Predictive Value of Tests
  • Polymorphism, Single Nucleotide
  • Oncology & Carcinogenesis
  • Middle Aged
  • Male